Fiona is an experienced patent attorney and handles a wide variety of work in the pharmaceutical, chemical and biotechnology fields.
The majority of Fiona’s work involves working with UK clients, and she has extensive experience in developing and implementing IP strategies that are aligned with commercial objectives.
Fiona deliberately tries to avoid becoming too focused on a particular sector, believing that the underlying principles of implementing an IP strategy can be applied across many industries, and to businesses of varying sizes. That said, Fiona is recognised for her expertise in pharmaceutical life cycle management, in particular, obtaining supplementary protection certificates (SPCs) and patent term extensions for approved drugs in a number of jurisdictions worldwide. She also has a particular interest in second medical use patents and has helped a number of clients achieve commercial success with re-purposed drugs.
Fiona is a regular attendee at International Federation of Intellectual Property Attorneys (FICPI) and American Intellectual Property Law Association (AIPLA) overseas conferences and also lectures on the CIPA Administrator course. In 2017, Fiona was recognised as one of Management Today’s ’35 under 35′ for her accomplishments in intellectual property. Fiona has successfully guided clients in the pharmaceutical industries through multiple fund-raising rounds and partnering successes, helping them raise well in excess of £300 million in investment over the past few years alone.
Fiona is a skilled prosecutor. She has an excellent understanding of client needs and can explain complex issues in easy-to-understand, actionable terms. She has deep knowledge of the biotech sector and is diligent and thorough in her approach.” IAM Patent 1000: The World’s Leading Patent Professionals, 2023
IAM Strategy 300: The World’s Leading IP Strategists, 2022
An invaluable resource for dynamic life sciences and chemical companies, Fiona Law is committed to ensuring her clients achieve commercial success; she fortifies portfolios with great commercial astuteness and can be counted on for advice that is sensitive to business and legal risk."
She is great to work with, is able to readily simplify concepts, and is not just a patent expert, but understands the commercial aspects of the biopharma and biotech industries well." IAM Patent 1000: The World’s Leading Patent Professionals, 2022